ETR Stock Overview
Engages in the research, development, and manufacture of disposable medical devices for dialysis in Bulgaria.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Etropal AD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | лв4.50 |
| 52 Week High | лв5.80 |
| 52 Week Low | лв4.00 |
| Beta | 0.13 |
| 1 Month Change | 2.27% |
| 3 Month Change | n/a |
| 1 Year Change | -22.41% |
| 3 Year Change | -21.05% |
| 5 Year Change | -14.29% |
| Change since IPO | -25.00% |
Recent News & Updates
Recent updates
We Think Etropal AD (BUL:ETR) Can Stay On Top Of Its Debt
Apr 13
Etropal AD (BUL:ETR) Is Making Moderate Use Of Debt
Mar 24Etropal AD (BUL:ETR) Use Of Debt Could Be Considered Risky
May 11We Think Etropal AD (BUL:5EO) Is Taking Some Risk With Its Debt
Jan 26
Should Weakness in Etropal AD's (BUL:5EO) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Dec 04Shareholder Returns
| ETR | BG Medical Equipment | BG Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -0.2% |
| 1Y | -22.4% | 7.4% | 15.7% |
Return vs Industry: ETR underperformed the BG Medical Equipment industry which returned 7.4% over the past year.
Return vs Market: ETR underperformed the BG Market which returned 15.7% over the past year.
Price Volatility
| ETR volatility | |
|---|---|
| ETR Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BG Market | 8.2% |
| 10% least volatile stocks in BG Market | 1.9% |
Stable Share Price: ETR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ETR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 96 | Lyubomir Kolchev | www.etropal.eu |
Etropal AD engages in the research, development, and manufacture of disposable medical devices for dialysis in Bulgaria. The company offers capillary dialyzers; arterial-venous(A/V) blood line sets; procedure kits; and A/V fistula needles. The company was founded in 1976 and is headquartered in Etropole, Bulgaria.
Etropal AD Fundamentals Summary
| ETR fundamental statistics | |
|---|---|
| Market cap | лв22.50m |
| Earnings (TTM) | -лв178.00k |
| Revenue (TTM) | лв11.20m |
2.0x
P/S Ratio-126.4x
P/E RatioIs ETR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ETR income statement (TTM) | |
|---|---|
| Revenue | лв11.20m |
| Cost of Revenue | лв7.16m |
| Gross Profit | лв4.04m |
| Other Expenses | лв4.22m |
| Earnings | -лв178.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.036 |
| Gross Margin | 36.08% |
| Net Profit Margin | -1.59% |
| Debt/Equity Ratio | 51.0% |
How did ETR perform over the long term?
See historical performance and comparison